Jazz Pharmaceuticals gets Cramer's vote of confidence
Jazz Pharmaceuticals (JAZZ) has had a rough couple of weeks. The drugmaker closed at $218.42 on Friday, Oct. 9, down about 11% over the past month and roughly 7% over the last five trading days.
14 Oct 00:33 · The Fresno Bee